Paid-members only Start-Upomics Featured Reports of NanoString's death appear to have been severely overstated
Paid-members only Genomic Sequencing Featured Illumina ruffled some feathers this week with a video appeal to moderate sized "core labs"
Paid-members only Start-Upomics Featured Francis deSouza is back from his post-Illumina purgatory with a new AI start-up
Paid-members only Genomics Featured Complete Genomics wants America to give them a second chance. Should they?
Paid-members only Start-Upomics Featured Is the life sciences bankruptcy bloodbath waxing or waning? Let's hope Nanostring and Invitae aren't emblematic of what's to come!
Paid-members only Conferenceomics Featured There was a lot of 'omics sizzle at this years' AGBT, and I'm not talking about the wicked sun-burns
Paid-members only Illumina Featured Add open-source sequencers to the list of things short-read manufacturers have to deal with now
Paid-members only Start-Upomics Featured RavGen got Natera to cough up $57m. What's going on with non-invasive screening test IP?
Paid-members only Conferenceomics Featured A round-up of everything omics that happened at the JP Morgan Healthcare Conference
Paid-members only Start-Upomics Featured 23andMe has been in the news recently about a data breach, raising important questions about data security in the age of genomics
Paid-members only Proteomics Featured It was a bad week for plasma proteomics darlings Olink and SomaLogic
Paid-members only Genomics Featured With the FDA setting up camp in LDT-ville, which sequencing companies are best suited to help labs transition to IVDs?
